The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online June 26, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0804076
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0804076v1
183/2/953    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Perruche, S.
Right arrow Articles by Chen, W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perruche, S.
Right arrow Articles by Chen, W.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH

Lethal Effect of CD3-Specific Antibody in Mice Deficient in TGF-β1 by Uncontrolled Flu-Like Syndrome1

Sylvain Perruche*,2,3, Pin Zhang*,2, Takashi Maruyama*, Jeffrey A. Bluestone{dagger}, Philippe Saas{ddagger} and WanJun Chen*,4

*Mucosal Immunology Unit, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892; {dagger}University of California-San Francisco Diabetes Center, San Francisco, CA 94143; and {ddagger}INSERM UMR645, University of Franche-Comte, Establissement Francais du Sana de Bourgogne Franche Comte, Institut Federatif de Recherche 133, Besançon, France

CD3-specific Ab therapy results in a transient, self-limiting, cytokine-associated, flu-like syndrome in experimental animals and in patients, but the underlying mechanism for this spontaneous resolution remains elusive. By using an in vivo model of CD3-specific Ab-induced flu-like syndrome, we show in this paper that a single injection of sublethal dose of the Ab killed all TGF-β1–/– mice. The death of TGF-β1–/– mice was associated with occurrence of this uncontrolled flu-like syndrome, as demonstrated by a sustained storm of systemic inflammatory TNF and IFN-{gamma} cytokines. We present evidence that deficiency of professional phagocytes to produce TGF-β1 after apoptotic T cell clearance may be responsible, together with hypersensitivity of T cells to both activation and apoptosis, for the uncontrolled inflammation. These findings indicate a key role for TGF-β1 and phagocytes in protecting the recipients from lethal inflammation and resolving the flu-like syndrome after CD3-specific Ab treatment. The study may also provide a novel molecular mechanism explaining the early death in TGF-β1–/– mice.

4 Address correspondence and reprint requests to Dr. W. J. Chen, National Institute of Dental and Craniofacial Research/National Institutes of Health, 30 Convent Drive, Building 30, Room 304, Bethesda, MD 20892. E-mail address: wchen{at}mail.nih.gov

1 This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Dental and Craniofacial Research. P.S. is supported by grants from the Institut National du Cancer (PL098) and the Association de Recherche contre le Cancer (3851).

2 S.P. and P.Z. contributed equally to this work.

3 Current address: INSERM UMR645, 1 Boulevard A Fleming, F-25020 Besançon, France.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.